D. Büchser

428 total citations
31 papers, 307 citations indexed

About

D. Büchser is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, D. Büchser has authored 31 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in D. Büchser's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (17 papers) and Advanced Radiotherapy Techniques (13 papers). D. Büchser is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (17 papers) and Advanced Radiotherapy Techniques (13 papers). D. Büchser collaborates with scholars based in Spain, France and Belgium. D. Büchser's co-authors include L. Cerezo, Mario López, Alicia Marín, M. Martín, Laura M. Fernández, Alfonso Gómez‐Iturriaga, Jon Cacicedo, F. Casquero, A. Zapatero and Pedro Bilbao and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Urology.

In The Last Decade

D. Büchser

28 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Büchser Spain	8	178	105	81	51	50	31	307
Abhishek A. Solanki United States	9	142 0.8×	113 1.1×	85 1.0×	43 0.8×	53 1.1×	37	279
Priyanka Patel United Kingdom	9	142 0.8×	71 0.7×	42 0.5×	45 0.9×	87 1.7×	23	251
Giulio Alberto Carta Italy	9	167 0.9×	68 0.6×	42 0.5×	53 1.0×	36 0.7×	19	285
Jennifer Le Guévelou France	9	98 0.6×	60 0.6×	51 0.6×	35 0.7×	36 0.7×	33	186
D Jacqmin United States	8	112 0.6×	89 0.8×	116 1.4×	65 1.3×	87 1.7×	19	286
Yonghua Yu China	10	144 0.8×	74 0.7×	47 0.6×	71 1.4×	57 1.1×	20	251
Wojciech Majewski Poland	12	144 0.8×	40 0.4×	71 0.9×	139 2.7×	83 1.7×	56	340
Alex Agranovich Canada	8	226 1.3×	55 0.5×	142 1.8×	32 0.6×	11 0.2×	13	345
Ryan Neff United States	4	81 0.5×	89 0.8×	45 0.6×	76 1.5×	95 1.9×	6	318
J. Coffey United Kingdom	7	144 0.8×	84 0.8×	84 1.0×	133 2.6×	37 0.7×	11	301

Countries citing papers authored by D. Büchser

Since Specialization

Citations

This map shows the geographic impact of D. Büchser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Büchser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Büchser more than expected).

Fields of papers citing papers by D. Büchser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Büchser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Büchser. The network helps show where D. Büchser may publish in the future.

Co-authorship network of co-authors of D. Büchser

This figure shows the co-authorship network connecting the top 25 collaborators of D. Büchser. A scholar is included among the top collaborators of D. Büchser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Büchser. D. Büchser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Guix, B., Tamer Soror, Beatriz Y. Salazar Vázquez, et al.. (2025). High-Dose-Rate brachytherapy for salvage treatment of prostate cancer recurrence post-prostatectomy and radiotherapy: A multicenter retrospective analysis (HDR-REPOPRA) by UroGEC. Radiotherapy and Oncology. 212. 111145–111145.

2.

Gómez‐Iturriaga, Alfonso, B. Guix, D. Büchser, et al.. (2025). Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGEC. Radiotherapy and Oncology. 210. 111042–111042. 1 indexed citations

3.

Linares, Estefanía, I. Rivero Belenchón, Gemma Sancho, et al.. (2024). PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform.. Journal of Clinical Oncology. 42(23_suppl). 192–192.

4.

Gómez‐Iturriaga, Alfonso, D. Büchser, Fernando López‐Campos, & Xavier Maldonado. (2024). Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities. Clinical and Translational Radiation Oncology. 45. 100733–100733. 4 indexed citations

5.

Linares, Estefanía, I. Rivero Belenchón, Gemma Sancho, et al.. (2024). PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform.. Journal of Clinical Oncology. 42(16_suppl). e23190–e23190. 1 indexed citations

6.

López‐Campos, Fernando, et al.. (2024). Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?. Cancers. 16(13). 2331–2331. 2 indexed citations

7.

Rivas, Juan Gómez, D. Büchser, Thomas Zilli, et al.. (2023). Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?. Clinical Genitourinary Cancer. 22(1). 56–66. 4 indexed citations

8.

López‐Campos, Fernando, D. Büchser, Xavier Maldonado, et al.. (2022). Bone health and therapeutic agents in advanced prostate cancer. Frontiers in Bioscience-Landmark. 27(1). 34–34. 5 indexed citations

9.

Lamo-Espinosa, José María, D. Büchser, F. Casquero, et al.. (2021). Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control. Journal of Contemporary Brachytherapy. 13(1). 12–17. 2 indexed citations

10.

Manini, Claudia, D. Büchser, Roberto Llarena, et al.. (2020). Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer. Journal of Personalized Medicine. 10(4). 265–265. 3 indexed citations

11.

Gómez‐Iturriaga, Alfonso, D. Büchser, Lorea Martínez‐Indart, et al.. (2020). Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial. Radiotherapy and Oncology. 146. 16–20. 11 indexed citations

12.

Büchser, D., F. Casquero, José María Lamo-Espinosa, et al.. (2019). Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study. Radiotherapy and Oncology. 135. 13–18. 7 indexed citations

13.

Gómez‐Iturriaga, Alfonso, F. Casquero, José Ignacio Pijoán, et al.. (2018). Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 101(5). 1172–1178. 6 indexed citations

14.

Zapatero, A., et al.. (2018). Impact of rectum and bladder anatomy in intrafractional prostate motion during hypofractionated radiation therapy. Clinical & Translational Oncology. 21(5). 607–614. 11 indexed citations

15.

Büchser, D., et al.. (2018). Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer. Urology. 124. 183–190. 15 indexed citations

16.

Gómez‐Iturriaga, Alfonso, F. Casquero, José Ignacio Pijoán, et al.. (2017). Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial. Radiotherapy and Oncology. 126(2). 278–282. 18 indexed citations

17.

Zapatero, A., et al.. (2017). Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer. Clinical & Translational Oncology. 19(9). 1161–1167. 23 indexed citations

18.

Martín, M., et al.. (2016). Products based on olive oil, betaine, and xylitol in the post-radiotherapy xerostomia. Reports of Practical Oncology & Radiotherapy. 22(1). 71–76. 12 indexed citations

19.

Büchser, D., Alfonso Gómez‐Iturriaga, F. Casquero, et al.. (2016). Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy. Journal of Contemporary Brachytherapy. 6(6). 477–483. 11 indexed citations

20.

Marín, Alicia, M. Martín, Mario López, et al.. (2014). Bystander effects and radiotherapy. Reports of Practical Oncology & Radiotherapy. 20(1). 12–21. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact